Literature DB >> 11410826

Insulin, renin-aldosterone system and blood pressure in obese people.

G Andronico1, S Cottone, M T Mangano, R Ferraro-Mortellaro, G Baiardi, N Grassi, L Ferrara, G Mulé, G Cerasola.   

Abstract

OBJECTIVE: To evaluate the relationship between insulin, the renin-aldosterone system and blood pressure in obese subjects. DESIGN AND METHODS: A cross sectional study of a group of severely obese normotensive subjects who were surgical candidates (n=39; mean BMI: 47.8+/-1.4) and a group of hypertensive patients (n=57; mean BMI: 28.0+/-0.7) twenty-nine of whom had BMI>27. All subjects were studied after 15 days on a balanced diet. Insulin, plasma renin activity and aldosterone were measured.
RESULTS: Fasting insulin, plasma renin activity and aldosterone were higher in severely obese normotensive subjects than in hypertensive subjects (respectively 32.3+/-3.0 vs 13.1+/-1.0 mU/l, P=0.0001; 1.34+/-0.22 vs 0.88+/-0.12 ng/ml/h, P=0.04; 137.2+/-16.2 vs 87.9+/-12.1 pg/ml, P=0.015). Insulin was related to BMI and to aldosterone both in normotensive and in hypertensive patients.
CONCLUSION: Hyperinsulinemia itself does not determine hypertension; in some people it could play a vasodilator role in opposition to the renin-aldosterone system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410826     DOI: 10.1038/sj.ijo.0801483

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  9 in total

Review 1.  A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.

Authors:  J B Byrd; R D Brook
Journal:  J Hum Hypertens       Date:  2013-05-23       Impact factor: 3.012

Review 2.  Aldosterone and cardiovascular risk.

Authors:  Bruno Vogt; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

3.  Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.

Authors:  R Garg; L Kneen; G H Williams; G K Adler
Journal:  Diabetes Obes Metab       Date:  2013-10-31       Impact factor: 6.577

4.  The role of aldosteronism in causing obesity-related cardiovascular risk.

Authors:  David A Calhoun; Kumar Sharma
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

Review 5.  The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease.

Authors:  Jessica L Faulkner; Thiago Bruder-Nascimento; Eric J Belin de Chantemèle
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-03       Impact factor: 2.894

Review 6.  Metabolic syndrome in hypertensive patients: An unholy alliance.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Emilio Nardi; Giovanni Cerasola; Santina Cottone
Journal:  World J Cardiol       Date:  2014-09-26

7.  Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.

Authors:  Tanja Dudenbostel; Lama Ghazi; Mingchun Liu; Peng Li; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-08-15       Impact factor: 10.190

8.  Mineralocorticoid receptors modulate vascular endothelial function in human obesity.

Authors:  Moon-Hyon Hwang; Jeung-Ki Yoo; Meredith Luttrell; Han-Kyul Kim; Thomas H Meade; Mark English; Mark S Segal; Demetra D Christou
Journal:  Clin Sci (Lond)       Date:  2013-12       Impact factor: 6.124

9.  Obesity and the diagnostic accuracy for primary aldosteronism.

Authors:  Amit Tirosh; Fady Hannah-Shmouni; Charalampos Lyssikatos; Elena Belyavskaya; Mihail Zilbermint; Smita B Abraham; Maya B Lodish; Constantine A Stratakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-06-13       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.